sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks (S)-Amisulpride

(S)-Amisulpride

CAS No.:
71675-92-8
Catalog Number:
AG00FGIP
Molecular Formula:
Molecular Weight:
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG00FGIP
Chemical Name:
(S)-Amisulpride
CAS Number:
71675-92-8
MDL Number:
MFCD04112982
IUPAC Name:
4-amino-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-5-ethylsulfonyl-2-methoxybenzamide
InChI:
InChI=1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)/t12-/m0/s1
InChI Key:
NTJOBXMMWNYJFB-LBPRGKRZSA-N
UNII:
ES3TWM82E8
Properties
Complexity:
549  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
369.172g/mol
Formal Charge:
0
Heavy Atom Count:
25  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
369.48g/mol
Monoisotopic Mass:
369.172g/mol
Rotatable Bond Count:
7  
Topological Polar Surface Area:
110A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.5  
Literature
Title Journal
Development and validation of amisulpride in human plasma by HPLC coupled with tandem mass spectrometry and its application to a pharmacokinetic study. Scientia pharmaceutica 20110101
Amisulpride: a review of its use in the management of schizophrenia. CNS drugs 20040101
THE LESSA (Lebanese Short-term Study with Amisulpride) STUDY a Phase IV clinical trial in acutely ill schizophrenic patients. Le Journal medical libanais. The Lebanese medical journal 20040101
Properties